Skip to main content
ScholarsBetaWeill Cornell Medicine

Publications

71 publications

Funding

19 grants

Active

3 grants
  • Co-I
    The effects of iron on oxidative stress and Alzheimer's biomarkers in amyloid-positive and negative elderly normal
    National Institute on Aging · 2020–2027
    R01AG068398-05
  • Co-I
    Mechanistic Assessment of N-Acetylcysteine as an Antioxidant Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Through Dose Response and Treatment Target Engagement
    National Institute of Neurological Disorders and Stroke · 2020–2027
    R01NS116887-05
  • Co-I
    Treatment Strategies for Mitochondrial Disease
    U.S. Department of Defense · 2022–2026 · via Columbia University
    W81XWH-20-1-0807
Completed grants (16)
  • Co-I
    Service agreement with Neuronasal, Inc. (2025)
    Neuronasal · 2025–2025Contract
    SA 253159-01
  • Co-I
    The Gulf War Illness Clinical Trials and Interventions Consortium (GWICTIC)
    U.S. Department of Defense · 2020–2025 · via Nova Southeastern University
    W81XWH-18-2-0062
  • Co-I
    Biomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia
    National Institute of Mental Health · 2017–2023
    R01MH110270-05
  • Co-I
    Cornell ME/CFS Collaborative Research Center
    National Institute of Neurological Disorders and Stroke · 2017–2023 · via Cornell University - Ithaca
    U54NS105541-04
  • Co-I
    Biomarkers and Brain Mechanisms of Gulf War Illness
    U.S. Department of Defense · 2015–2022
    W81XWH-15-1-0437
  • Co-I
    Treatment Strategies for Mitochondrial Disease
    U.S. Department of Defense · 2020–2021 · via Columbia University Medical Center_
    W81XWH-19-PRMRP-FPA
  • Co-I
    Mitochondrial Encephalomyopathies: Approaches to Treatment
    Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2014–2020 · via Columbia University
    P01HD080642-05
  • KP
    Neuroinflammation and PVS Deficits in Adolescents
    National Institute of Mental Health · 2014–2018 · via Mount Sinai School of Medicine
    5 R01 MH10479-04
  • KP
    Specificity and Validity of Oxidative Stress Model of Chronic Fatigue Syndrome
    National Institute of Mental Health · 2013–2017
    R01MH100005-03
  • KP
    The Neuroimmunology of Anhedonia
    National Institute of Mental Health · 2012–2017 · via New York University School of Medicine (Grossman)
    R01MH095807-05
  • KP
    Novel OCD Medication Strategies to Target Brain Mechanisms in Adolescents
    National Institute of Mental Health · 2012–2017
    R34MH095377-03
  • KP
    N-Acetylcysteine for Neuroprotection in Parkinsons Disease
    National Institute on Aging · 2011–2016
    R21AG041509-02 EW
  • KP
    The Antidepressant Action of Ketamine: Brain Chemistry
    National Institute of Mental Health · 2011–2016
    R01MH093637-04
  • KP
    Mitochondrial Encephalomyopathies and Mental Retardation
    Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2011–2016 · via Columbia University· 2 renewals
    P01HD032062-20
  • KP
    Neuropathologic Abnormalities Define A Subgroup of Patients with CFS
    National Institute of Neurological Disorders and Stroke · 2011–2015 · via Beth Israel Medical Center
    R21NS075653-02
  • KP
    NAC for Treatment of Oxidative Stress in Chronic Fatigue Syndrome
    National Institute of Nursing Research · 2012–2015
    R21NR013650-01A1